CN103007084A - Traditional Chinese medicine for treating liver cancer and preparation method of traditional Chinese medicine - Google Patents
Traditional Chinese medicine for treating liver cancer and preparation method of traditional Chinese medicine Download PDFInfo
- Publication number
- CN103007084A CN103007084A CN2012105824916A CN201210582491A CN103007084A CN 103007084 A CN103007084 A CN 103007084A CN 2012105824916 A CN2012105824916 A CN 2012105824916A CN 201210582491 A CN201210582491 A CN 201210582491A CN 103007084 A CN103007084 A CN 103007084A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- fructus
- traditional chinese
- subsequent use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 201000007270 liver cancer Diseases 0.000 title abstract description 6
- 208000014018 liver neoplasm Diseases 0.000 title abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 20
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 20
- 238000002560 therapeutic procedure Methods 0.000 claims description 18
- 241000258241 Mantis Species 0.000 claims description 14
- 241000217407 Margaritifera Species 0.000 claims description 14
- 240000000249 Morus alba Species 0.000 claims description 14
- 235000008708 Morus alba Nutrition 0.000 claims description 14
- 239000002775 capsule Substances 0.000 claims description 14
- 208000001840 Dandruff Diseases 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000005266 casting Methods 0.000 claims description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000013505 freshwater Substances 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 3
- 238000009738 saturating Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 240000001972 Gardenia jasminoides Species 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 10
- 238000011282 treatment Methods 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000007812 deficiency Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 239000013589 supplement Substances 0.000 abstract 2
- 235000007070 Angelica archangelica Nutrition 0.000 abstract 1
- 240000007087 Apium graveolens Species 0.000 abstract 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000252185 Cobitidae Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241001533104 Tribulus terrestris Species 0.000 abstract 1
- 244000081822 Uncaria gambir Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 230000005713 exacerbation Effects 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000003786 wild celery Nutrition 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 description 9
- 241000157835 Gardenia Species 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000052343 Dares Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010073069 Hepatic cancer Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000006990 cholangiocarcinoma Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 201000007450 intrahepatic cholangiocarcinoma Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating liver cancer and a preparation method for the traditional Chinese medicine, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine for treating the liver cancer consists of the following raw materials in parts by weight: 15-30 parts of puncturevine caltrop fruits, 10-16 parts of dipsacus roots, 8-15 parts of dragon bones, 10-18 parts of mantisegg-case, 12-20 parts of licorice roots, 5-10 parts of eucommia barks, 15-20 parts of cape jasmine fruits, 5-8 parts of rhizoma gastrodiae, 10-20 parts of nacre, 5-9 parts of gambir plants, 10-18 parts of bighead atractylodes rhizome, 8-15 parts of finger citron, 8-15 parts of corn stigma, 8-12 parts of wildcelery herbs and 4-8 live loaches. The traditional Chinese medicine for treating the liver cancer can sooth the liver-qi to remove stagnation, tonify the qi to supplement the deficiency, and supplements the liver and tonify the kidney, so that the symptoms are improved, the immunity of the organism is increased, and the exacerbation speed is low to strive for the time for other auxiliary treatments; and moreover, the medicine has no toxic and side effect, and the price can be easily accepted by common families.
Description
Technical field
The present invention relates to Chinese medicine of Hepatoma therapy and preparation method thereof, belong to technical field of Chinese medicines.
Background technology
Hepatocarcinoma refers to betide the malignant tumor of liver, comprises two kinds of primary hepatocarcinoma and secondary liver cancers, and mostly the hepatocarcinoma of the daily theory of people is primary hepatocarcinoma if referring to.Primary hepatocarcinoma is one of modal malignant tumor clinically, and according to recent statistics, the annual new liver cancer patient in the whole world approximately 600,000 occupies the 5th of malignant tumor.Primary hepatocarcinoma can be divided into Hepatocellular carcinoma, intrahepatic cholangiocarcinoma and mixed carcinoma of liver by cell typing.Form by tumor can be divided into nodular type, massive type and diffuse type.Primary hepatocarcinoma belongs to high morbidity in China, and general male is more than the women.China is hepatitis B big country, and the hepatocarcinoma of China is many to be developed on the basis of hbv-liver cirrhosis, and the hepatitis C patient also increasing gradually, also can develop into hepatocarcinoma after the hepatitis B.China's number of the infected accounts for the more than half of the whole world at present, accounts for 55% of global hepatocarcinoma patient, has become a large killer of serious threat China people health and lives, and its danger can not look down upon.The general method that all adopts operative treatment and Drug therapy, but a lot of patients can not be treated surgically owing to a variety of causes, Drug therapy adopts Western medicine mostly, the therapeutic effect of Western medicine is not obvious, also often with complication, and expensive, average family holds at all dares not accept, and has delayed patient's golden hour.
Summary of the invention
The object of the invention is to solve the weak point that above-mentioned prior art exists, thus provide a kind of evident in efficacy, have no side effect, can improve symptom, delay the Chinese medicine and preparation method thereof that PD speed prolongs the Hepatoma therapy in patient's life-span.
The present invention is achieved by the following technical solutions:
A kind of Chinese medicine of Hepatoma therapy, its special character are to be comprised of following raw material by weight ratio: Fructus Tribuli 15-30 part, Radix Dipsaci 10-16 part, Os Draconis 8-15 part, Mulberry egg capsule of mantis 10-18 part, Radix Glycyrrhizae 12-20 part, Cortex Eucommiae 5-10 part, Fructus Gardeniae 15-20 part, Rhizoma Gastrodiae 5-8 part, Concha Margaritifera 10-20 part, Ramulus Uncariae Cum Uncis 5-9 part, Rhizoma Atractylodis Macrocephalae 10-18 part, Fructus Citri Sarcodactylis 8-15 part, Stigma Maydis 8-15 part, Herba Apii graveolentis 8-12 part, live loacs 4-8 bar;
The Chinese medicine of described Hepatoma therapy is comprised of following raw material by weight ratio: Fructus Tribuli 18-30 part, Radix Dipsaci 12-16 part, Os Draconis 10-15 part, Mulberry egg capsule of mantis 10-15 part, Radix Glycyrrhizae 12-18 part, Cortex Eucommiae 8-10 part, Fructus Gardeniae 15-18 part, Rhizoma Gastrodiae 5-7 part, Concha Margaritifera 10-18 part, Ramulus Uncariae Cum Uncis 5-8 part, Rhizoma Atractylodis Macrocephalae 10-16 part, Fructus Citri Sarcodactylis 10-15 part, Stigma Maydis 12-15 part, Herba Apii graveolentis 9-12 part, live loacs 4-7 bar;
The Chinese medicine of described Hepatoma therapy is comprised of the raw material of following by weight optimal proportion: 20 parts of Fructus Tribulis, 12 parts of Radix Dipsaci, 14 parts of Os Draconis, 15 parts of the Mulberry egg capsule of mantis, 15 parts in Radix Glycyrrhizae, 8 parts of the Cortexs Eucommiae, 16 parts of Fructus Gardeniaes, 6 parts in Rhizoma Gastrodiae, 15 parts of Concha Margaritiferas, 8 parts of Ramulus Uncariae Cum Uncis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Citri Sarcodactylis, 15 parts of Stigma Maydis, 10 parts of Herba Apii graveolentis, 6 of live loacses;
A kind of preparation method of Chinese medicine of Hepatoma therapy, its special character is may further comprise the steps:
(1) Radix Dipsaci is cleaned silt, remove the retained root head, run through rear section and dry, sieve anti-dandruff, for subsequent use; Os Draconis outwash earth dries for subsequent use; Rhizoma Gastrodiae is soaked in water to seventy percent saturating, pulls out, slightly dries in the air, and profit is even to inside and outside humidity again, and section is dried for subsequent use; Fish for shell, remove meat, earth, clean, put into aqueous alkali and boil, then put into fresh water and embathe, take out, scrape off outer casting skin, dry and make Concha Margaritifera; Impurity is cleaned, removed to live loacs, and section is dried for subsequent use; With Fructus Tribuli, the Mulberry egg capsule of mantis, Radix Glycyrrhizae, the Cortex Eucommiae, Fructus Gardeniae, Ramulus Uncariae Cum Uncis, the Rhizoma Atractylodis Macrocephalae, that Fructus Citri Sarcodactylis weighs up corresponding umber is for subsequent use;
(2) Stigma Maydis clean dry for subsequent use; It is for subsequent use that Herba Apii graveolentis presses into juice;
(3) with the raw material pulverizing of step (1) to the 60-80 order, abundant mix homogeneously adds the raw material of step (2) again;
(4) with the raw material slow fire boiling of step (3) 1-2 hour, taking liquid was taken and is got final product.
The effect of each Chinese medicinal components:
Fructus Tribuli: hot, bitter, tepor; The suppressing the hyperactive liver resolving depression, promoting blood circulation by removing wind;
Radix Dipsaci: bitter in the mouth; Hot; Slightly warm in nature; Invigorating the liver and kidney; Bone and muscle strengthening; Blood circulation regulating;
Os Draconis: sweet puckery, flat; Astringing QI ends night sweat by wet, calms the nerves;
The Mulberry egg capsule of mantis: sweet in the mouth; Salty; Property is put down; The special astringent therapy of merit;
Radix Glycyrrhizae: sweet in the mouth, property is flat, heat-clearing and toxic substances removing;
The Cortex Eucommiae: acrid in the mouth is flat; Invigorating the liver and kidney, bone and muscle strengthening;
Fructus Gardeniae: bitter, cold, pathogenic fire purging relieving restlessness; Clearing away heat-damp and promoting diuresis; Removing pathogenic heat from blood and toxic substance from the body;
Rhizoma Gastrodiae: sweet flat, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral;
Concha Margaritifera: salty-cold; Suppressing the hyperactive liver and subsiding YANG; The arresting convulsion of calming the nerves;
Ramulus Uncariae Cum Uncis: sweetness and bitterness; Be slightly cold; The heat clearing away suppressing the hyperactive liver; Relieving spasm by subduing liver-wind;
The Rhizoma Atractylodis Macrocephalae: bitter in the mouth; Sweet; Invigorating the spleen and benefiting QI warm in nature;
Fructus Citri Sarcodactylis: hot, sweet, bitter, the warm dispersing the stagnated live-QI to relieve the stagnation of QI of nature and flavor, drying dampness to eliminate phlegm;
Stigma Maydis: sweet, flat; The suppressing the hyperactive liver function of gallbladder promoting;
Herba Apii graveolentis: cool in nature, sweet in the mouth is hot, clearing heat and relieving fidgetness, suppressing the hyperactive liver;
Live loacs: sweet in the mouth, property is flat, invigorating spleen and kidney.
The Chinese medicine of Hepatoma therapy of the present invention can dispersing the stagnated live-QI to relieve the stagnation of QI, QI invigorating tonify deficiency, the liver and the kidney tonifying, thereby improves symptom, enhancing human body immunity power delays the speed that sb.'s illness took a turn for the worse, for other auxiliary treatment are raced against time, and have no side effect, price also can allow average family more easily accept.
The specific embodiment
Below provide the specific embodiment of the present invention, be used for formation of the present invention is described in further detail.
Embodiment 1
The Chinese medicine of the present embodiment Hepatoma therapy is comprised of following raw material by weight ratio: 15 parts of Fructus Tribulis, 10 parts of Radix Dipsaci, 8 parts of Os Draconis, 10 parts of the Mulberry egg capsule of mantis, 12 parts in Radix Glycyrrhizae, 5 parts of the Cortexs Eucommiae, 15 parts of Fructus Gardeniaes, 5 parts in Rhizoma Gastrodiae, 10 parts of Concha Margaritiferas, 5 parts of Ramulus Uncariae Cum Uncis, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 8 parts of Fructus Citri Sarcodactylis, 8 parts of Stigma Maydis, 8 parts of Herba Apii graveolentis, 4 of live loacses.
Embodiment 2
The Chinese medicine of the present embodiment Hepatoma therapy is comprised of following raw material by weight ratio: 30 parts of Fructus Tribulis, 16 parts of Radix Dipsaci, 15 parts of Os Draconis, 18 parts of the Mulberry egg capsule of mantis, 20 parts in Radix Glycyrrhizae, 10 parts of the Cortexs Eucommiae, 20 parts of Fructus Gardeniaes, 8 parts in Rhizoma Gastrodiae, 20 parts of Concha Margaritiferas, 9 parts of Ramulus Uncariae Cum Uncis, 18 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Fructus Citri Sarcodactylis, 15 parts of Stigma Maydis, 12 parts of Herba Apii graveolentis, 8 of live loacses.
Embodiment 3
The Chinese medicine of the present embodiment Hepatoma therapy, it is comprised of following raw material by weight ratio: 20 parts of Fructus Tribulis, 14 parts of Radix Dipsaci, 12 parts of Os Draconis, 14 parts of the Mulberry egg capsule of mantis, 16 parts in Radix Glycyrrhizae, 8 parts of the Cortexs Eucommiae, 18 parts of Fructus Gardeniaes, 6 parts in Rhizoma Gastrodiae, 15 parts of Concha Margaritiferas, 6 parts of Ramulus Uncariae Cum Uncis, 14 parts of the Rhizoma Atractylodis Macrocephalaes, 12 parts of Fructus Citri Sarcodactylis, 12 parts of Stigma Maydis, 10 parts of Herba Apii graveolentis, 6 of live loacses.
Embodiment 4
The present embodiment
The Chinese medicine of the present embodiment Hepatoma therapy is comprised of the raw material of following by weight optimal proportion: 20 parts of Fructus Tribulis, 12 parts of Radix Dipsaci, 14 parts of Os Draconis, 15 parts of the Mulberry egg capsule of mantis, 15 parts in Radix Glycyrrhizae, 8 parts of the Cortexs Eucommiae, 16 parts of Fructus Gardeniaes, 6 parts in Rhizoma Gastrodiae, 15 parts of Concha Margaritiferas, 8 parts of Ramulus Uncariae Cum Uncis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Citri Sarcodactylis, 15 parts of Stigma Maydis, 10 parts of Herba Apii graveolentis, 6 of live loacses.
The preparation method of the Chinese medicine of above embodiment Hepatoma therapy may further comprise the steps:
(1) Radix Dipsaci is cleaned silt, remove the retained root head, run through rear section and dry, sieve anti-dandruff, for subsequent use; Os Draconis outwash earth dries for subsequent use; Rhizoma Gastrodiae is soaked in water to seventy percent saturating, pulls out, slightly dries in the air, and profit is even to inside and outside humidity again, and section is dried for subsequent use; Fish for shell, remove meat, earth, clean, put into aqueous alkali and boil, then put into fresh water and embathe, take out, scrape off outer casting skin, dry and make Concha Margaritifera; Impurity is cleaned, removed to live loacs, and section is dried for subsequent use; With Fructus Tribuli, the Mulberry egg capsule of mantis, Radix Glycyrrhizae, the Cortex Eucommiae, Fructus Gardeniae, Ramulus Uncariae Cum Uncis, the Rhizoma Atractylodis Macrocephalae, that Fructus Citri Sarcodactylis weighs up corresponding umber is for subsequent use;
(2) Stigma Maydis clean dry for subsequent use; It is for subsequent use that Herba Apii graveolentis presses into juice;
(3) with raw material pulverizing to 60 order of step (1), abundant mix homogeneously adds the raw material of step (2) again;
(4) with the raw material slow fire boiling of step (3) 2 hours, taking liquid was taken and is got final product.
Clinical case:
1, Wang, man, 50 years old, the patient removes hospital admission because an awful ache in the belly, is diagnosed as hepatocellular carcinoma, after through operative treatment etc. and to no effect, and with a series of complication, cause physical weakness, take Chinese medicine of the present invention after, the state of an illness is obviously improved, and body immunity strengthens, and swelling disappears, through check, each index is all normal, continues now to take, to recovery from illness.
2, Liu, the woman, 60 years old, the patient felt fatigue always, diet reduces, be diagnosed as primary hepatocarcinoma through examination in hospital, owing to being not suitable for operative treatment, have to take Western medicine, but take after three courses for the treatment of still invalid, the symptoms such as vomiting, diarrhoea also appear, take tiredly behind the medicine of the present invention disappear, diet increases, and shows after the check that each index is all normal, without transfer phenomena.
3, hot certain, the man, 45 years old, conscious malaise, become thin, in examination in hospital is found liver, lump is arranged, surgical result is also not obvious, take medicine of the present invention after above symptom obviously alleviate, just continuing now to take, do not find new focus after the check.
Claims (4)
1. the Chinese medicine of a Hepatoma therapy is characterized in that being comprised of following raw material by weight ratio: Fructus Tribuli 15-30 part, Radix Dipsaci 10-16 part, Os Draconis 8-15 part, Mulberry egg capsule of mantis 10-18 part, Radix Glycyrrhizae 12-20 part, Cortex Eucommiae 5-10 part, Fructus Gardeniae 15-20 part, Rhizoma Gastrodiae 5-8 part, Concha Margaritifera 10-20 part, Ramulus Uncariae Cum Uncis 5-9 part, Rhizoma Atractylodis Macrocephalae 10-18 part, Fructus Citri Sarcodactylis 8-15 part, Stigma Maydis 8-15 part, Herba Apii graveolentis 8-12 part, live loacs 4-8 bar.
2. the Chinese medicine of described a kind of Hepatoma therapy according to claim 1 is characterized in that being comprised of following raw material by weight ratio: Fructus Tribuli 18-30 part, Radix Dipsaci 12-16 part, Os Draconis 10-15 part, Mulberry egg capsule of mantis 10-15 part, Radix Glycyrrhizae 12-18 part, Cortex Eucommiae 8-10 part, Fructus Gardeniae 15-18 part, Rhizoma Gastrodiae 5-7 part, Concha Margaritifera 10-18 part, Ramulus Uncariae Cum Uncis 5-8 part, Rhizoma Atractylodis Macrocephalae 10-16 part, Fructus Citri Sarcodactylis 10-15 part, Stigma Maydis 12-15 part, Herba Apii graveolentis 9-12 part, live loacs 4-7 bar.
3. the Chinese medicine of described a kind of Hepatoma therapy according to claim 1 is characterized in that being comprised of the raw material of following by weight optimal proportion: 20 parts of Fructus Tribulis, 12 parts of Radix Dipsaci, 14 parts of Os Draconis, 15 parts of the Mulberry egg capsule of mantis, 15 parts in Radix Glycyrrhizae, 8 parts of the Cortexs Eucommiae, 16 parts of Fructus Gardeniaes, 6 parts in Rhizoma Gastrodiae, 15 parts of Concha Margaritiferas, 8 parts of Ramulus Uncariae Cum Uncis, 12 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Fructus Citri Sarcodactylis, 15 parts of Stigma Maydis, 10 parts of Herba Apii graveolentis, 6 of live loacses.
4. the preparation method of the Chinese medicine of described a kind of Hepatoma therapy according to claim 1-3 is characterized in that may further comprise the steps:
(1) Radix Dipsaci is cleaned silt, remove the retained root head, run through rear section and dry, sieve anti-dandruff, for subsequent use; Os Draconis outwash earth dries for subsequent use; Rhizoma Gastrodiae is soaked in water to seventy percent saturating, pulls out, slightly dries in the air, and profit is even to inside and outside humidity again, and section is dried for subsequent use; Fish for shell, remove meat, earth, clean, put into aqueous alkali and boil, then put into fresh water and embathe, take out, scrape off outer casting skin, dry and make Concha Margaritifera; Impurity is cleaned, removed to live loacs, and section is dried for subsequent use; With Fructus Tribuli, the Mulberry egg capsule of mantis, Radix Glycyrrhizae, the Cortex Eucommiae, Fructus Gardeniae, Ramulus Uncariae Cum Uncis, the Rhizoma Atractylodis Macrocephalae, that Fructus Citri Sarcodactylis weighs up corresponding umber is for subsequent use;
(2) Stigma Maydis clean dry for subsequent use; It is for subsequent use that Herba Apii graveolentis presses into juice;
(3) with the raw material pulverizing of step (1) to the 60-80 order, abundant mix homogeneously adds the raw material of step (2) again;
(4) with the raw material slow fire boiling of step (3) 1-2 hour, taking liquid was taken and is got final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105824916A CN103007084B (en) | 2012-12-28 | 2012-12-28 | Preparation method of traditional Chinese medicine for treating liver cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105824916A CN103007084B (en) | 2012-12-28 | 2012-12-28 | Preparation method of traditional Chinese medicine for treating liver cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103007084A true CN103007084A (en) | 2013-04-03 |
| CN103007084B CN103007084B (en) | 2013-12-18 |
Family
ID=47956548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105824916A Active CN103007084B (en) | 2012-12-28 | 2012-12-28 | Preparation method of traditional Chinese medicine for treating liver cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103007084B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208484A (en) * | 2014-09-22 | 2014-12-17 | 殷永洲 | Traditional Chinese medicine granules for treating liver cancer |
| CN104622935A (en) * | 2015-03-23 | 2015-05-20 | 傅宇晓 | Traditional Chinese medicine composition for treating hepatitis and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1772255A (en) * | 2005-09-27 | 2006-05-17 | 韩云超 | Chinese medicine for treating liver cancer and carcinoma of pancreas |
| CN101288763A (en) * | 2008-06-10 | 2008-10-22 | 东莞市得世生物科技有限公司 | Medicine for treating liver cancer and preparing process thereof |
| CN101716280A (en) * | 2009-12-23 | 2010-06-02 | 刘建国 | Medicine composite used for curing liver cancer |
| CN102488809A (en) * | 2012-01-04 | 2012-06-13 | 英山县杨柳湾中心卫生院 | Traditional Chinese medicine used for treating liver cancer, and preparation method thereof |
-
2012
- 2012-12-28 CN CN2012105824916A patent/CN103007084B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1772255A (en) * | 2005-09-27 | 2006-05-17 | 韩云超 | Chinese medicine for treating liver cancer and carcinoma of pancreas |
| CN101288763A (en) * | 2008-06-10 | 2008-10-22 | 东莞市得世生物科技有限公司 | Medicine for treating liver cancer and preparing process thereof |
| CN101716280A (en) * | 2009-12-23 | 2010-06-02 | 刘建国 | Medicine composite used for curing liver cancer |
| CN102488809A (en) * | 2012-01-04 | 2012-06-13 | 英山县杨柳湾中心卫生院 | Traditional Chinese medicine used for treating liver cancer, and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208484A (en) * | 2014-09-22 | 2014-12-17 | 殷永洲 | Traditional Chinese medicine granules for treating liver cancer |
| CN104622935A (en) * | 2015-03-23 | 2015-05-20 | 傅宇晓 | Traditional Chinese medicine composition for treating hepatitis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103007084B (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103908640B (en) | A kind of Chinese medicine composition for the treatment of cirrhosis | |
| CN103655979A (en) | Traditional Chinese medicine composition for treating conjunctivitis | |
| CN103536748A (en) | Traditional Chinese medicament for treating goiter with depression of liver to generate pathogenic fire | |
| CN103800650A (en) | Traditional Chinese medicine for clearing lung and eliminating phlegm | |
| CN103007084B (en) | Preparation method of traditional Chinese medicine for treating liver cancer | |
| CN103520352B (en) | The Chinese medicine for the treatment of stasis blocking venation pattern of syndrome obstruction of qi in the chest and cardialgia | |
| CN101647966A (en) | Traditional Chinese medicine for treating appendicitis and preparation method thereof | |
| CN101375962B (en) | Formulation for activating blood and freeing collateral vessels and preparation method thereof | |
| CN103656199B (en) | A kind of Chinese medicine for the treatment of deficiency of kidney yin syndrome cough | |
| CN104587417A (en) | Spleen-invigorating and diuresis-promoting preparation for patients with earlier period cirrhosis and a preparation method | |
| CN104208442A (en) | Traditional Chinese medicine for treating meniere disease and preparation method thereof | |
| CN103041220A (en) | Chinese herbal medicine for treating eczema | |
| CN104547875A (en) | Traditional Chinese medicine for treating arteries and veins stasis type chest stuffiness and pain | |
| CN103007202A (en) | Traditional Chinese medicine composition for treating pancreatic cancer | |
| CN107898968A (en) | Chinese medicinal preparation method with health-care effect | |
| CN106668753A (en) | Hui-nationality traditional Chinese medicine toad pills for treating breast cancer and preparation method thereof | |
| CN103735811B (en) | A kind of external-applied ointment and preparation method for the treatment of tinea versicolor | |
| CN104922551A (en) | Oral solution for treating toxic heat flourishing type needle eye and preparing method of oral solution | |
| CN104922595A (en) | Traditional Chinese medicinal preparation for herpes zoster and preparation method thereof | |
| CN102988819A (en) | Chinese herbal medicine for treating eczema | |
| CN104352823A (en) | Traditional Chinese medicine formula for treating epilepsy | |
| CN104257865A (en) | Chinese herba preparation for treating toothache | |
| CN113827691A (en) | Composition for relieving sports fatigue and chronic fatigue syndrome and preparation method thereof | |
| CN101934004A (en) | Chinese herbal medicament for treating urinary infections | |
| CN107961336A (en) | A kind of Chinese medicine composition of invigorating the spleen defaecation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: 264003 Yantai high tech Zone, China Agricultural University, Shandong (Yantai campus) Applicant after: Liu Yaohua Address before: Zhifu District of Shandong city of Yantai Province Yu 264000 West Road, room 205 No. 17-6 Applicant before: Liu Yaohua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Free format text: FORMER OWNER: LIU YAOHUA Effective date: 20150514 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264003 YANTAI, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150514 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 264003 Yantai high tech Zone, China Agricultural University, Shandong (Yantai campus) Patentee before: Liu Yaohua |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20200410 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220117 Address after: Fengli town Xinjian West Road, Rudong County, Nantong City, Jiangsu Province 226400 Patentee after: Rudong Wenyuan investment and Development Co.,Ltd. Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240115 Address after: No. 45, Menmen Group, Anshui Village, Mashi Town, Shixing County, Shaoguan City, Guangdong Province, 512000 Patentee after: Lu Defu Patentee after: Lu Quanjin Address before: Fengli town Xinjian West Road, Rudong County, Nantong City, Jiangsu Province 226400 Patentee before: Rudong Wenyuan investment and Development Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240517 Address after: No. 45, Menmen Group, Anshui Village, Mashi Town, Shixing County, Shaoguan City, Guangdong Province, 512000 Patentee after: Lu Defu Country or region after: China Address before: No. 45, Menmen Group, Anshui Village, Mashi Town, Shixing County, Shaoguan City, Guangdong Province, 512000 Patentee before: Lu Defu Country or region before: China Patentee before: Lu Quanjin |
|
| TR01 | Transfer of patent right |